February 10, 2025 - 21:02
Gorilla Technology has announced the termination of its At-The-Market (ATM) program, a strategic decision aimed at bolstering investor confidence and safeguarding against potential dilution. This bold move reflects the company's commitment to maintaining the integrity of its share value while emphasizing a stronger focus on revenue growth and long-term value creation.
In a statement, the CEO expressed that this decision aligns with the company's vision of fostering a solid financial foundation. By discontinuing the ATM program, Gorilla Technology aims to reassure its investors that their interests are a top priority. The company is now redirecting its efforts towards enhancing operational efficiency and driving sustainable growth.
This proactive step comes at a time when many companies are exploring various funding options, but Gorilla Technology's choice to eliminate the ATM program signals a clear dedication to building trust with its stakeholders. The management team is optimistic about future prospects and is committed to delivering substantial returns to investors.
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...